Novel Anti-Cancer Strategy: Targeting Integrin Beta3 PSI Domain Simultaneously Impedes Cancer Angiogenesis, Metastasis and Thrombosis

新型抗癌策略：靶向整合素 Beta3 PSI 结构域同时阻止癌症血管生成、转移和血栓形成

• 批准号: 466843
• 负责人: Rousseau Zackary
• 金额: $ 1.27万
• 依托单位: University of Toronto
• 依托单位国家: 加拿大
• 项目类别: Studentship Programs
• 财政年份: 2021
• 资助国家: 加拿大
• 起止时间: 2021-12-01 至 2022-12-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=466843&lang=en
• 关键词: Beta3; Cancer; Integrins; Platelets

Cancer remains the primary cause of death in Canada due to its ability to spread throughout the body, and create secondary complications of cancer-associated thrombotic disease, or in other words a blockage in the circulatory system. Platelets, which we a

癌症仍然是加拿大的主要死亡原因，因为它能够扩散到全身，并产生与癌症相关的血栓性疾病的继发性并发症，或者换句话说，循环系统堵塞。简单，我们